Information on Formulation Development
When it comes to pharmaceutical companies the earlier a compound can be killed or proved ineffective the better. Formulation development is a very important step in the drug development process and is now critical to a compound s lifecycle. Proving that a compound is ineffective is not an easy job considering the New Chemical Entities (NCEs) in the wake of a mapped genome as well as automated testing technologies.
The pharmaceutical companies focus more on R&D and commercialization while the drug development itself is being sent out to separate contract providers. This type of actions have been going on for years except for the fact that contract providers aren t only associating with big pharmaceutical companies anymore. Up and coming biotech companies seem to lack drug development capabilities which gives more business to a pharmaceutical company and biopharmaceutical outsourcing industry.
Considering the drug development contract service providers have been working side by side with the pharmaceutical companies for years they are more than ready and willing to take on all of the new business. In fact by the late nineties many of these companies were able to become experts at small molecule formulation development. These companies that had the ability to perform pre-formulation and regular formulation development services could have their clients get rid of a compound or tell them to let it survive while offering key money and time saving decisions.
One of the largest problems that are facing formulation development providers is solubility. If you contact anyone in this industry they will also agree that this is the major issue. Large molecule targets are water insoluble and formulators are working as hard as they can to take care of this issue. Companies are not only trying to discover new ways to formulate these new drug targets but they also have to keep the regulatory issues in mind too.
Written by Joshua Gibbson. Find the more information on formulation development.